Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDK14 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | HSD17B10 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | PLA2G4B | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | ANXA6 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | SLC38A10 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | VEGFB | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | METTL14 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | GOLGA6L9 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | KLHL38 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | ZFP36L1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |